Evidence map›Paper›PMID 32042586›Full record

ArticleLeukemia research reports2020

Toshie Ogasawara, Kiyotaka Kawauchi, Takuya Ono, Shoko Marshall, Kotaro Shide, Kazuya Shimoda, Naoki Mori, Hiroshi Sakura

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Toshie OgasawaraTokyo Women's Medical University, Medical Center East, Department of medicine, 2-1-10, Nishiogu Arakawa-ku, Tokyo 116-8569, Japan.
Kiyotaka KawauchiTokyo Women's Medical University, Medical Center East, Department of medicine, 2-1-10, Nishiogu Arakawa-ku, Tokyo 116-8569, Japan.
Takuya OnoTokyo Women's Medical University, Medical Center East, Department of medicine, 2-1-10, Nishiogu Arakawa-ku, Tokyo 116-8569, Japan.
Shoko MarshallTokyo Women's Medical University, Medical Center East, Department of Medicine, Tokyo Joshi Ika Daigaku Higashi Iryo Center.
Kotaro ShideUniversity of Miyazaki, Depertment of Internal Medicine II, 5200, Kihara, Kiyotake, Miyazaki 889-1692, Japan.
Kazuya ShimodaUniversity of Miyazaki, Depertment of Internal Medicine II, 5200, Kihara, Kiyotake, Miyazaki 889-1692, Japan.
Naoki MoriTokyo Women's Medical University, Medical Center East, Department of medicine, 2-1-10, Nishiogu Arakawa-ku, Tokyo 116-8569, Japan.
Hiroshi SakuraTokyo Women's Medical University, Medical Center East, Department of medicine, 2-1-10, Nishiogu Arakawa-ku, Tokyo 116-8569, Japan.
Tokyo Women's Medical University Adachi Medical Center · JPUniversity of Miyazaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Essential thrombocythemia (ET) is an indolent myeloproliferative neoplasm (MPN) with a transformation to acute myeloid leukemia in <5% of patients. A 79-year-old man with

Indexed as

10–11 Translocation 2 proteinAcute monocytic leukemiaEssential thrombocythemiaJanus activating kinase 2Myeloproliferative neoplasm

Identifiers

PMID32042586
PMCPMC6997900
OpenAlexW2999274443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.